Doxapram vs no treatment, placebo, methylxanthine (including theophylline, aminophylline, or caffeine), or
Failed apnea reduction · treatment of apnea
Doxapram showed no clear difference in 1a. Failed apnea reduction after 2–7 days – doxapram compared to no… compared with no treatment, placebo, methylxanthine (including theophylline,… (low certainty).
3 findings from 1 review
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.45 [0.2, 1.05]1 study · 21 participantsLow
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyRR 1.35 [0.53, 3.45]4 studies · 84 participantsVery low
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.08 [0.01, 1.17]1 study · 10 participantsVery low